National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05DB	DIANEAL PD4 2.27% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 22.7g/l		Injectable solution	1,163,270 L.L
C05CA53	DAFLON	B	Hesperidin - 100mg, Diosmin - 900mg		Tablet, film coated	1,256,493 L.L
B05DB	DIANEAL PD4 CYCLER 2.27% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 22.7g/l		Injectable solution	1,150,329 L.L
B05DB	DIANEAL PD4 3.86% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 38.6g/l		Injectable solution	1,111,506 L.L
B05DB	DIANEAL PD4 CYCLER 3.86% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 38.6g/l		Injectable solution	1,150,329 L.L
S01ED51	DUOTRAV	B	Timolol (maleate) - 5mg, Travoprost - 40mcg		Drops solution	1,933,789 L.L
B03BA51	DEPOVEX	B	Aluminium monostearate - 20mg/ml, Cyanocobalamine - 1mg/ml		Injectable oily suspension	423,310 L.L
J02AC01	DIFLUCAN	B	Fluconazole - 50mg	50mg	Capsule	622,199 L.L
M03BX	DORIXINA RELAX	B	Lysine clonixinate - 125mg, Cyclobenzaprine HCl - 5mg		Tablet, film coated	581,884 L.L
J02AC01	DIFLUCAN	B	Fluconazole - 150mg	150mg	Capsule	286,238 L.L
H02AB01	DIPROFOS	B	Betamethasone (dipropionate) - 5mg/ml, Betamethasone (sodium phosphate) - 2mg/ml		Injectable suspension	446,156 L.L
H02AB02	DECADRON	B	Dexamethasone - 0.5mg/5ml	0.5mg/5ml	Elixir	449,227 L.L
A02BC06	DEXILANT	B	Dexlansoprazole - 30mg	30mg	Capsule, delayed release	1,595,141 L.L
A02BC06	DEXILANT	B	Dexlansoprazole - 60mg	60mg	Capsule, delayed release	2,375,914 L.L
A02BC07	DEXPURE	B	Dexrabeprazole sodium - 10mg	10mg	Tablet, enteric coated	517,379 L.L
H02AB02	DECADRON	B	Dexamethasone - 0.5mg	0.5mg	Tablet, scored	378,240 L.L
L01BC08	DACOGEN	B	Decitabine - 50mg	50mg	Injectable lyophilised powder for solution	87,048,758 L.L
L01BC08	DACOGEN	B	Decitabine - 50mg	50mg	Injectable lyophilised powder for solution	87,048,758 L.L
A03AA04	DUSPATALIN RETARD	B	Mebeverine HCl - 200mg	200mg	Capsule	861,466 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 200mg/3.47ml	200mg/3.47ml	Syrup	442,124 L.L
D01AC02	DAKTARIN	B	Miconazole nitrate - 20mg/g	20mg/g	Cream	231,141 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 200mg/ml	200mg/ml	Solution	360,150 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 500mg	500mg	Tablet, enteric coated	479,752 L.L
A12AX	DECALCIT	B	Vitamin D3 - 500IU, Calcium - 600mg		Tablet	912,469 L.L
A12AX	DECALCIT	B	Vitamin D3 - 500IU, Calcium - 600mg		Tablet	348,055 L.L
H02AB04	DEPO MEDROL	B	Methylprednisolone acetate - 40mg/ml	40mg/ml	Injectable suspension	182,763 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 200mg	200mg	Tablet, enteric coated	240,548 L.L
D01AC14	DERMOFIX	B	Sertaconazole nitrate - 20mg/g	2%	Cream	382,995 L.L
H02AB04	DEPO MEDROL	B	Methylprednisolone acetate - 80mg/2ml	80mg/2ml	Injectable suspension	365,525 L.L
N03AG01	DEPAKINE	B	Sodium Valproate - 400mg	400mg	Injectable lyophilised powder for solution+diluent	450,187 L.L

National Cancer Registry (NCR)